MONASH UNIVERSITY

MONASH UNIVERSITY logo
🇦🇺Australia
Ownership
Private
Established
1958-01-01
Employees
10K
Market Cap
-
Website
https://www.monash.edu/emerging-tech-research-lab
nature.com
·

Author Correction: Genetic variants in UNC93B1 predispose to childhood-onset systemic ...

Authors Mahmoud Al-Azab and Elina Idiiatullina contributed equally; Yuxia Zhang and Seth L. Masters jointly supervised. Affiliations include Guangzhou Institute of Paediatrics, Guangzhou Women and Children’s Medical Centre, University of Science and Technology, Aden, Bashkir State Medical University, Walter and Eliza Hall Institute, University of Melbourne, Guangzhou Medical University, Greater Bay Area Institute of Precision Medicine, Guangzhou Women and Children’s Medical Centre, Children’s Hospital of Fudan University, Sun Yat-sen University, Hudson Institute of Medical Research, and Monash University.
nature.com
·

Defining and pursuing diversity in human genetic studies

Article lists affiliations and authors from various institutions including Nuffield Council on Bioethics, Stanford University, McGill University, National Institutes of Health, and more, across multiple countries.
theguardian.com
·

Morning Mail: the 48-hour DVO danger period, pregnancy drug shortage, au revoir to the ...

Women face high risk in first 48 hours after seeking protection from family violence; pregnant women rely on older drugs vulnerable to supply chain disruptions; tourism industry faces climate crisis threats; Paris Paralympics conclude with a stunning closing ceremony; Sudan's ongoing war receives limited global attention; intervention order system for domestic violence needs reform; Guy Montgomery shares three useful objects; NSW considers banning helium balloons and reusable cups; final report of the royal commission into defence and veteran suicide to be handed down.
biospace.com
·

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Immuron completes pre-IND meeting with FDA on IMM-529 for Clostridioides difficile infection (CDI), plans IND application for 1H 2025, and targets prevention, recurrence protection, and treatment of CDI with a 3-target approach.
© Copyright 2024. All Rights Reserved by MedPath